Literature DB >> 7758025

Dentistry and the cancer patient: Part 2--Oral health management of the chemotherapy patient.

S E Semba1, B L Mealey, W W Hallmon.   

Abstract

The increase in the incidence of head and neck cancer has been accompanied by a more widespread use of chemotherapy. As a result, the dental community has frequent contact with patients who are undergoing or have undergone chemotherapy. In many of these patients, immunosuppression leads to an increased risk of infection, and the chemotherapeutic agents themselves can cause a variety of oral complications. The dentist must be familiar with available treatments for managing these conditions and for preventing further deterioration of oral and systemic health.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7758025

Source DB:  PubMed          Journal:  Compendium        ISSN: 0894-1009


  2 in total

1.  Efficacy of HPA Lanolin® in treatment of lip alterations related to chemotherapy.

Authors:  Paulo Sérgio da Silva Santos; José Endrigo Tinôco-Araújo; Lucas Monteiro de Vasconcelos Alves de Souza; Rafael Ferreira; Maura Rosane Valério Ikoma; Ana Paula Ribeiro Razera; Márcia Mirolde Magno de Carvalho Santos
Journal:  J Appl Oral Sci       Date:  2013 Mar-Apr       Impact factor: 2.698

Review 2.  Oral and dental considerations in pediatric leukemic patient.

Authors:  Chiyadu Padmini; K Yellamma Bai
Journal:  ISRN Hematol       Date:  2014-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.